CLLS — Cellectis SA Cashflow Statement
0.000.00%
Last trade - 00:00
- $146.43m
- -$21.31m
- $9.19m
- 25
- 48
- 40
- 32
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -115 | -97.5 | -125 | -98.7 | -117 |
Depreciation | |||||
Non-Cash Items | 20.7 | 26.6 | 7.15 | -2.71 | 20.7 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 18.5 | -19.2 | -3.18 | -4.48 | 52.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -69.1 | -80.3 | -105 | -87.4 | -24.7 |
Capital Expenditures | -13 | -46.3 | -19.7 | -2.44 | -1.07 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -22.9 | -8.08 | 27 | -0.32 | -14.4 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -35.9 | -54.3 | 7.28 | -2.76 | -15.5 |
Financing Cash Flow Items | -0.469 | 0.21 | 44.5 | 8.32 | 1.45 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -3.86 | 27.3 | 47.5 | 1.15 | 82.9 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -111 | -99.4 | -55.5 | -92.4 | 43.5 |